The average one-year price target for 10x Genomics (NasdaqGS:TXG) has been revised to $16.66 / share. This is an increase of 10.47% from the prior estimate of $15.08 dated November 7, 2025. The price ...
10x Genomics signals 5% sequential revenue growth for Q4 2025 as new product launches drive adoption
Taich stated, "We anticipate revenue to be in the range of $154 million to $158 million, representing 5% growth compared to Q3 at the midpoint." He explained, "We do not anticipate a material change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results